• Flexible, stable and potent against cancer

    19 days ago - By ScienceDaily

    Linking therapeutically active molecules to specific antibodies can help to pilot them to their designated targets and minimize side effects - especially when treating tumors. Scientists have now described novel conjugates made from antibodies and a kinesin spindle protein inhibitor. Changing the linker between the two components allows for tuning the activity of this cytostatic drug, which is effective against a broad palette of cancers.
    Read more ...

     

  • Scientists neutralize reactive nitrogen molecules to enhance cancer immunotherapy

    19 days ago - By ScienceDaily

    Researchers studying tumors in prostate cancer models found that nitration of an amino acid can inhibit T-cell activation, thwarting the T-cell's ability to kill cancer cells.
    Read more ...